Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Dec 6;73(11):2126-2130.
doi: 10.1093/cid/ciab239.

The Essential Role of Data and Safety Monitoring Boards (DSMBs) in Ensuring the Ethics of Global Vaccine Trials to Address Coronavirus Disease 2019 (COVID-19O)

Lisa Eckstein  1 , Annette Rid  2 , Dorcas Kamuya  3 , Seema K Shah  4   5
Affiliations

The Essential Role of Data and Safety Monitoring Boards (DSMBs) in Ensuring the Ethics of Global Vaccine Trials to Address Coronavirus Disease 2019 (COVID-19O)

Lisa Eckstein et al. Clin Infect Dis. .

Abstract

Coronavirus disease 2019 (COVID-19) vaccines are being developed and implemented with unprecedented speed. Accordingly, trials considered ethical at their inception may quickly become concerning. We provide recommendations for Data and Safety Monitoring Boards (DSMBs) on monitoring the ethical acceptability of COVID-19 vaccine trials, focusing on placebo-controlled trials in low- and middle-income countries.

Keywords: COVID-19 vaccines; SARS-CoV-2; clinical trials data monitoring committees; ethics, research; standard of care.

PubMed Disclaimer

References

    1. Zimmer C, Corum J, Wee S-L. Coronavirus vaccine tracker.The New York Times. Available at: https://www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tra.... Accessed 5 March 2021.
    1. Voysey M, Clemens SAC, Madhi SA, et al. ; Oxford COVID Vaccine Trial Group . Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet 2021; 397:99–111. - PMC - PubMed
    1. Wendler D, Ochoa J, Millum J, Grady C, Taylor HA. COVID-19 vaccine trial ethics once we have efficacious vaccines. Science 2020; 370:1277–9. - PMC - PubMed
    1. Rid A, Lipsitch M, Miller FG. The ethics of continuing placebo in SARS-CoV-2 vaccine trials. JAMA 2021; 325:219–20. - PubMed
    1. World Health Organization Access to COVID-19 Tools Accelerator Ethics and, Governance Working Group. Emergency use designation of COVID-19 candidate vaccines: ethical considerations for current and future COVID-19 placebo-controlled vaccine trials and trial unblinding. 2020; Available at: https://www.who.int/publications-detail-redirect/WHO-2019-nCoV-Policy_Br.... Accessed 22 December 2020.

Publication types